课题基金 / 基金详情

Identification of Human facilitating cells

Identification of Human facilitating cells
人类促进细胞的鉴定
批准号:
13670807
负责人:
SATO Takashi
金额:
$1.66万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2001
资助国家:
日本
项目状态:
已结题
起止时间:
2001 至 2002

项目摘要

项目成果

SATO Takashi的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We sought human facilitating cells using human / mouse xenon-transplantation model.Among human bone marrow CD8 positive cells, 30〜40% cells were positive for CD56 and 15 〜20% cells were CD161 positive. Bone marrow cells were sorted into CD8+CD56+, CD8+ CD56-, CD8+CD161+and CD8+CD161-using FACS Vantage as candidates for facilitating cells. Total bone marrow cells, CD34+c-kit+cells(stem cells), CD8+cells candidates for facilitating cells and stem cells plus candidates for facilitating cells were, respectively, transplanted into 300 cGy irradiated NOD / SCID mice. After 8 weeks in the transplantation, mice were sacrificed and the bone marrow cells were measured for human CD45 positive cells. Percentages of CD45 positive cells were 1 〜7% after total bone marrow cell transplantation, 3〜10% after stem cell transplantation, 0% after CD8 positive cell transplantation and candidates for facilitating cells, 3〜18% after stem cells plus candidates for facilitating cells transplantation. No significant differences were detected among the four candidates for facilitating cells plus candidates for facilitating cells transplantation. The low engrafting efficacy of the xenotransplantation was thought to cause the negative date, we then choose new born NOD / SCID β2microglobulin-/-mice as recipients. The engrafting efficacy was improved and over 90% of human CD45 positive cells were seen after total bone marrow cells transplantation. The study is still on going using the new xenon transplantation model.We have studied neutropenia of infancy and several new information were reported.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Masao Kobayashi: "Significance of the detection of antineutrophil antibodies in children with chronic neutropenia"Blood. 99・9. 3468-3471 (2002)
小林正夫:“慢性中性粒细胞减少症儿童抗中性粒细胞抗体检测的意义”血液99・9。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H. kawaguchi, T. Sato et al.: "Dysregulation of transcripts in primary granule constituents during myeloid proliferation and differentiation in patients with severe congenital neutropenia"Journal of Leukocyte Biology. 73. 225-234 (2003)
H. kawaguchi、T. Sato 等人:“严重先天性中性粒细胞减少症患者骨髓增殖和分化过程中初级颗粒成分转录物的失调”《白细胞生物学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kazuhiro Nakamura: "Defects of granulopoiesis in patients with severe congenital neutropenia"Hiroshima Journal of Medical Sciences. 51. 63-74 (2002)
Kazuhiro Nakamura:“严重先天性中性粒细胞减少症患者的粒细胞生成缺陷”《广岛医学科学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
K. Nakamura, T. Sato et al.: "Defects of granulopoiesis in patients with severe congenital neutropenia"Hiroshima Journal of Medical Sciences. 51(3). 63-74 (2002)
K. Nakamura、T. Sato 等人:“严重先天性中性粒细胞减少症患者的粒细胞生成缺陷”《广岛医学科学杂志》。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Peptide ligand screening of transthyretin protein-protein interaction inhibitor using phage display system
    • 批准号:
      16K18875
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.58万
    • 财政年份:
      2016
    • 负责人:
      SATO Takashi
    • 依托单位:
    Study of nanoparticles-incorporating immune modulating oligodeoxynucleotide for the treatment of lung diseases
    • 批准号:
      15K09224
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.08万
    • 财政年份:
      2015
    • 负责人:
      SATO Takashi
    • 依托单位:
    Evolution of the new competition policy by the open source strategy
    • 批准号:
      25380313
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.5万
    • 财政年份:
      2013
    • 负责人:
      SATO Takashi
    • 依托单位:
    Development of drugs targeting secretory inhibition of transthyretin for familial amyloidotic polyneuropathy
    • 批准号:
      24790079
    • 项目类别:
      Grant-in-Aid for Young Scientists (B)
    • 资助金额:
      $2.91万
    • 财政年份:
      2012
    • 负责人:
      SATO Takashi
    • 依托单位:
    海外基金